• Ceftolozane/Tazobactam: Mechanism and Evidence

  2026-08-14

  This 2015 review explains how pairing the antipseudomonal cephalosporin ceftolozane with tazobactam extends activity against important resistant Gram-negative pathogens. Its integration of mechanism, microbiology, pharmacokinetics, pharmacodynamics, clinical trials, and safety data provides a framework for interpreting β-lactam combination studies and designing translational infection experiments.

• Low-Cost Microfluidic Mixers for LNP Research

  2026-08-14

  Forrester and colleagues compared two low-cost microfluidic mixers with pipette mixing for lipid nanoparticle production and found that all approaches generated highly encapsulated LNPs across a 95–215 nm size range. The study shows that inexpensive methods can support formulation screening and produce expression trends that remain informative across in vitro and in vivo testing, while also emphasizing that detailed quality attributes can differ between mixing platforms.

• BV6 and Cell-Death Pathway Attribution

  2026-08-13

  Explore how BV6, an IAP antagonist, can distinguish apoptotic sensitization from lysosome-associated cell death. This mechanistic guide connects IAP biology, lysoptosis research, assay design, and preclinical cancer and endometriosis models.

• HyperTrap Heparin HP Column for Protein Purification

  2026-08-13

  The HyperTrap Heparin HP Column is a ready-to-use affinity chromatography format for heparin-binding biomolecules. Its HyperChrom Heparin HP Agarose medium combines a 34 μm average particle size with approximately 10 mg/mL ligand density for high-resolution research purification workflows.

• SB743921 Workflows for KSP-Driven Cancer Assays

  2026-08-12

  Build more informative mitotic-response assays with SB743921, a selective kinesin spindle protein inhibitor for separating growth inhibition from cell killing. This practical workflow combines controlled dosing, orthogonal readouts, and troubleshooting strategies for cancer research and preclinical translation.

• Sodium Overload and Mitochondrial NECSO

  2026-08-12

  Qiao et al. show that TRPM4-mediated sodium influx drives necrosis by disrupting mitochondrial ion homeostasis, oxidative metabolism, and ATP-dependent ion control. The study provides a mechanistic framework for connecting sodium overload with mitochondrial failure and highlights why membrane-potential measurements should be interpreted alongside metabolic and cell-death readouts.

• Liproxstatin-1: Ferroptosis Inhibitor Guide

  2026-08-11

  Liproxstatin-1 is a small-molecule ferroptosis inhibitor with a reported 22 nM IC50 in an RSL3-induced cell-death assay. It provides a research control for inhibition of lipid peroxidation, GPX4-deficient cell protection, and ferroptosis-linked renal injury models.

• NADPH Oxidase ROS Activate LTCC in Young Arteries

  2026-08-11

  This study identifies L-type voltage-gated Ca2+ channels as the principal downstream mediator of NADPH oxidase-derived ROS in methoxamine-induced contraction of saphenous arteries from early postnatal rats. Pharmacological experiments separated this pathway from Rho-kinase, PKC, and Src-kinase signaling, refining the developmental biology of ROS-dependent vascular tone.

• Gastric Cancer Assembloids for Patient-Specific Testing

  2026-08-10

  The reference study develops patient-derived gastric cancer assembloids by combining matched tumor organoids with stromal subpopulations from the same tumor. Its findings show that stromal composition changes gene expression and drug sensitivity, supporting more physiologically relevant cancer biology research and personalized treatment modeling.

• Adipose-Neural Control of Cardiac Arrhythmias

  2026-08-09

  Fan et al. developed a stem cell-based coculture model showing how epicardial adipose tissue can influence cardiac electrical instability through a leptin–sympathetic neuron–NPY–Y1R pathway. The study identifies NCX and CaMKII as downstream components and provides a useful framework for testing receptor-selective interventions while distinguishing the demonstrated Y1R mechanism from complementary Y2R research.

• Imatinib in Patient-Derived Tumor–Stroma Assays

  2026-08-08

  Imatinib (STI571) can reveal how stromal context reshapes kinase-dependent drug responses. This article translates patient-derived gastric cancer assembloid findings into a practical framework for interpreting target engagement, MAP kinase pathway inhibition, and resistance in physiologically relevant models.

• CTP Solution for p21 mRNA Transcription

  2026-08-07

  CTP Solution (100 mM) supports controlled IVT workflows for p21 mRNA and other RNA constructs intended for lipid nanoparticle research. Its defined concentration, high HPLC purity, and nuclease- and phosphatase-free formulation help connect nucleotide preparation with reproducible RNA quality and localized delivery studies.

• 1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine in Src Kinase P

  2026-08-07

  PP 3 (1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine) elevates the reliability of Src kinase signaling pathway research as a rigorously validated negative control compound. Its high purity and well-defined role in experimental design enable precise modulation and dissection of protein tyrosine kinase inhibition effects in cellular assays.

• Spatial Metabolomics Reveals DHA’s Protective Role in POCD R

  2026-08-06

  This study applies spatial metabolomics to dissect hippocampal lipid changes underlying postoperative cognitive dysfunction (POCD) following cardiopulmonary bypass in rats. It identifies key disruptions in lipid metabolism and demonstrates that targeting these pathways with docosahexaenoic acid (DHA) can mitigate cognitive impairment, highlighting a mechanistic link between hippocampal lipid homeostasis and POCD risk.

• Thapsigargin: SERCA Pump Inhibitor for Calcium Signaling Res

  2026-08-06

  Thapsigargin is a potent SERCA pump inhibitor that disrupts intracellular calcium homeostasis, enabling precise study of calcium signaling and endoplasmic reticulum stress in cell and animal models. Its nanomolar potency and reproducibility make it a benchmark tool for apoptosis and ER stress research.

16303 records 1/1087 page Next 12345 下5页 Last page